🔬 FREE Shipping on Orders Over $150  |  All Peptides Include COA  |  For Research Use Only  |  @CertPeptides

Tirzepatide – GIP/GLP-1 Dual Receptor Agonist – 10mg

GIP/GLP-1 Agonists

Tirzepatide – GIP/GLP-1 Dual Receptor Agonist – 10mg

$89.99

Tirzepatide is a GIP/GLP-1 receptor dual agonist that activates both glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. A potent research compound for advanced metabolic studies.

Molecular Weight:~3724.05 g/mol
Purity:≥98% (HPLC)
Form:Lyophilized powder
Storage:-20°C
✔ Third-Party Tested
✔ COA Included
✔ 98%+ Purity
✔ Fast Shipping

Product Description

Tirzepatide is a GIP/GLP-1 receptor dual agonist that activates both glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously. This dual mechanism provides a unique pharmacological profile for metabolic research, offering enhanced effects on glucose homeostasis and energy metabolism.

Specifications

Molecular Weight ~3724.05 g/mol
Purity ≥98% (HPLC)
Physical Form Lyophilized powder
Storage -20°C, keep away from light and moisture

Research Applications

  • GIP and GLP-1 receptor binding and dual-agonist signaling studies
  • Glucose homeostasis and insulin secretion research
  • Energy expenditure and metabolic rate studies
  • Comparative efficacy vs. single GLP-1 agonists

Disclaimer: This product is intended for laboratory and research use only. Not for human or animal consumption. All handling should be conducted by qualified researchers in accordance with applicable regulations.

Certificate of Analysis

Every batch of Tirzepatide sold by CertPeptides is independently tested by a third-party laboratory. The Certificate of Analysis (COA) confirms identity, purity (≥98% via HPLC), and the absence of heavy metals and microbial contamination.

A COA is included with every order. You may also request a batch-specific COA through our contact page.

Laboratory Product Information

📦 Includes

One (1) vial of Tirzepatide lyophilized powder (10mg per vial), Certificate of Analysis (COA).

🔬 Purpose

Tirzepatide is a dual GIP/GLP-1 receptor agonist utilized in in-vitro receptor binding assays, cAMP dose–response studies, and metabolic pathway investigations. It provides a unique research tool for studying the synergistic effects of simultaneous GIP and GLP-1 receptor activation.

🧬 Ingredients

Tirzepatide dual GIP/GLP-1 receptor agonist lyophilized powder, ≥98% purity (HPLC verified). No fillers, binders, or excipients.

🔬 Laboratory Handling Information

  • Molecular Weight: ~3724.05 Da
  • Purity: ≥98% (HPLC)
  • Solubility: Soluble in sterile aqueous buffers (e.g., bacteriostatic water, PBS) at concentrations suitable for in-vitro applications
  • Storage: Store lyophilized product at 2–8°C; reconstituted aliquots at −20°C; avoid repeated freeze-thaw cycles
  • Literature Reference: Referenced at 1–100 nM for in-vitro GIP/GLP-1 receptor binding affinity and metabolic research assays

🚨 IMPORTANT — RESEARCH USE ONLY

FOR RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY CONSUMPTION. Not intended for any in vivo use, therapeutic, or diagnostic purpose. No dosing or administration information provided or implied.

🚚 Shipping

Ships in temperature-controlled packaging via priority courier. Most orders ship within 24 hours on business days. Free shipping on orders over $150. Tracking number provided via email upon shipment.